Comprehensive Analysis of GSEC/miR-101-3p/SNX16/PAPOLG Axis in Hepatocellular Carcinoma

Overview

Journal PLoS One

Specialties General Medicine
Science

Date 2022 Apr 28

PMID 35482720

Authors

Shangshang Hu

Jinyan Zhang

Guoqing Guo

Li Zhang

Jing Dai

Yu Gao

Affiliations

Soon will be listed here.

Abstract

Hepatocellular carcinoma (HCC) is one of the most lethal malignancies. A growing number of studies have shown that competitive endogenous RNA (ceRNA) regulatory networks might play important roles during HCC process. The present study aimed to identify a regulatory axis of the ceRNA network associated with the development of HCC. The roles of SNX16 and PAPOLG in HCC were comprehensively analyzed using bioinformatics tools. Subsequently, the "mRNA-miRNA-lncRNA" model was then used to predict the upstream miRNAs and lncRNAs of SNX16 and PAPOLG using the miRNet database, and the miRNAs with low expression and good prognosis in HCC and the lncRNAs with high expression and poor prognosis in HCC were screened by differential expression and survival analysis. Finally, the risk-prognosis models of ceRNA network axes were constructed by univariate and multifactorial Cox proportional risk analysis, and the immune correlations of ceRNA network axes were analyzed using the TIMER and GEPIA database. In this study, the relevant ceRNA network axis GSEC/miR-101-3p/SNX16/PAPOLG with HCC prognosis was constructed, in which GSEC, SNX16, and PAPOLG were highly expressed in HCC with poor prognosis, while miR-101-3p was lowly expressed in HCC with good prognosis. The risk-prognosis model predicted AUC of 0.691, 0.623, and 0.626 for patient survival at 1, 3, and 5 years, respectively. Immuno-infiltration analysis suggested that the GSEC/miR-101-3p/SNX16/PAPOLG axis might affect macrophage polarization. The GSEC/miR-101-3p/SNX16/PAPOLG axis of the ceRNA network axis might be an important factor associated with HCC prognosis and immune infiltration.

Citing Articles

MiR-101-3p Promotes Tumor Cell Proliferation and Migration via the Wnt Signal Pathway in MNNG-Induced Esophageal Squamous Cell Carcinoma.

Wang J, Zhang W, Zhang R, Yang H, Li Y, Wang J Toxics. 2024; 12(11).

PMID: 39591002 PMC: 11598764. DOI: 10.3390/toxics12110824.

Data augmentation based on the WGAN-GP with data block to enhance the prediction of genes associated with RNA methylation pathways.

Jiang T, Shen C, Ding P, Luo L Sci Rep. 2024; 14(1):26321.

PMID: 39487188 PMC: 11530642. DOI: 10.1038/s41598-024-77107-0.

SNX16 is required for hepatocellular carcinoma survival via modulating the EGFR-AKT signaling pathway.

Yuan L, Meng Y, Xiang J Sci Rep. 2024; 14(1):13093.

PMID: 38849490 PMC: 11161632. DOI: 10.1038/s41598-024-64015-6.

A disulfidptosis-related lncRNA signature for predicting prognosis and evaluating the tumor immune microenvironment of lung adenocarcinoma.

Song Z, Cao X, Wang X, Li Y, Zhang W, Wang Y Sci Rep. 2024; 14(1):4621.

PMID: 38409243 PMC: 10897395. DOI: 10.1038/s41598-024-55201-7.

The role of competing endogenous RNA network in the development of hepatocellular carcinoma: potential therapeutic targets.

Tang Z, Li X, Zheng Y, Liu J, Liu C, Li X Front Cell Dev Biol. 2024; 12:1341999.

PMID: 38357004 PMC: 10864455. DOI: 10.3389/fcell.2024.1341999.

References

Kursun D, Kucuk C . Systematic analysis of the frequently amplified 2p15-p16.1 locus reveals PAPOLG as a potential proto-oncogene in follicular and transformed follicular lymphoma. Turk J Biol. 2019; 43:124-132. PMC: 6667098. DOI: 10.3906/biy-1810-2. View

Tang Z, Li C, Kang B, Gao G, Li C, Zhang Z . GEPIA: a web server for cancer and normal gene expression profiling and interactive analyses. Nucleic Acids Res. 2017; 45(W1):W98-W102. PMC: 5570223. DOI: 10.1093/nar/gkx247. View

Shen Z, Li Y, Fang Y, Lin M, Feng X, Li Z . SNX16 activates c-Myc signaling by inhibiting ubiquitin-mediated proteasomal degradation of eEF1A2 in colorectal cancer development. Mol Oncol. 2019; 14(2):387-406. PMC: 6998659. DOI: 10.1002/1878-0261.12626. View

Li B, Mao R, Liu C, Zhang W, Tang Y, Guo Z . LncRNA FAL1 promotes cell proliferation and migration by acting as a CeRNA of miR-1236 in hepatocellular carcinoma cells. Life Sci. 2018; 197:122-129. DOI: 10.1016/j.lfs.2018.02.006. View

Liu Z, Wang Y, Wang L, Yao B, Sun L, Liu R . Long non-coding RNA AGAP2-AS1, functioning as a competitive endogenous RNA, upregulates ANXA11 expression by sponging miR-16-5p and promotes proliferation and metastasis in hepatocellular carcinoma. J Exp Clin Cancer Res. 2019; 38(1):194. PMC: 6518827. DOI: 10.1186/s13046-019-1188-x. View

Yang W, Lu Y, Xu Y, Xu L, Zheng W, Wu Y . Estrogen represses hepatocellular carcinoma (HCC) growth via inhibiting alternative activation of tumor-associated macrophages (TAMs). J Biol Chem. 2012; 287(48):40140-9. PMC: 3504728. DOI: 10.1074/jbc.M112.348763. View

Li C, Pang Y, Yang H, Li J, Lu H, Wang H . Identification of miR-101-3p targets and functional features based on bioinformatics, meta-analysis and experimental verification in hepatocellular carcinoma. Am J Transl Res. 2017; 9(5):2088-2105. PMC: 5446495. View

Yao R, Li J, Zhang R, Chen R, Wang Y . M2-polarized tumor-associated macrophages facilitated migration and epithelial-mesenchymal transition of HCC cells via the TLR4/STAT3 signaling pathway. World J Surg Oncol. 2018; 16(1):9. PMC: 5771014. DOI: 10.1186/s12957-018-1312-y. View

Schmitt A, Chang H . Long Noncoding RNAs in Cancer Pathways. Cancer Cell. 2016; 29(4):452-463. PMC: 4831138. DOI: 10.1016/j.ccell.2016.03.010. View

10.

Zhao X, Qu J, Sun Y, Wang J, Liu X, Wang F . Prognostic significance of tumor-associated macrophages in breast cancer: a meta-analysis of the literature. Oncotarget. 2017; 8(18):30576-30586. PMC: 5444766. DOI: 10.18632/oncotarget.15736. View

11.

Wang H, Huo X, Yang X, He J, Cheng L, Wang N . STAT3-mediated upregulation of lncRNA HOXD-AS1 as a ceRNA facilitates liver cancer metastasis by regulating SOX4. Mol Cancer. 2017; 16(1):136. PMC: 5558651. DOI: 10.1186/s12943-017-0680-1. View

12.

Cui M, Wang H, Yao X, Zhang D, Xie Y, Cui R . Circulating MicroRNAs in Cancer: Potential and Challenge. Front Genet. 2019; 10:626. PMC: 6656856. DOI: 10.3389/fgene.2019.00626. View

13.

Cao Z, Pan X, Yang Y, Huang Y, Shen H . The lncLocator: a subcellular localization predictor for long non-coding RNAs based on a stacked ensemble classifier. Bioinformatics. 2018; 34(13):2185-2194. DOI: 10.1093/bioinformatics/bty085. View

14.

Teasdale R, Collins B . Insights into the PX (phox-homology) domain and SNX (sorting nexin) protein families: structures, functions and roles in disease. Biochem J. 2011; 441(1):39-59. DOI: 10.1042/BJ20111226. View

15.

. Comprehensive and Integrative Genomic Characterization of Hepatocellular Carcinoma. Cell. 2017; 169(7):1327-1341.e23. PMC: 5680778. DOI: 10.1016/j.cell.2017.05.046. View

16.

Balogh J, Victor 3rd D, Asham E, Burroughs S, Boktour M, Saharia A . Hepatocellular carcinoma: a review. J Hepatocell Carcinoma. 2016; 3:41-53. PMC: 5063561. DOI: 10.2147/JHC.S61146. View

17.

Strillacci A, Valerii M, Sansone P, Caggiano C, Sgromo A, Vittori L . Loss of miR-101 expression promotes Wnt/β-catenin signalling pathway activation and malignancy in colon cancer cells. J Pathol. 2012; 229(3):379-89. DOI: 10.1002/path.4097. View

18.

Yang Q, Nausch L, Martin G, Keller W, Doublie S . Crystal structure of human poly(A) polymerase gamma reveals a conserved catalytic core for canonical poly(A) polymerases. J Mol Biol. 2013; 426(1):43-50. PMC: 3878066. DOI: 10.1016/j.jmb.2013.09.025. View

19.

Golabi P, Fazel S, Otgonsuren M, Sayiner M, Locklear C, Younossi Z . Mortality assessment of patients with hepatocellular carcinoma according to underlying disease and treatment modalities. Medicine (Baltimore). 2017; 96(9):e5904. PMC: 5340426. DOI: 10.1097/MD.0000000000005904. View

20.

Ivanovska I, Zhang C, Liu A, Wong K, Lee N, Lewis P . Gene signatures derived from a c-MET-driven liver cancer mouse model predict survival of patients with hepatocellular carcinoma. PLoS One. 2011; 6(9):e24582. PMC: 3174972. DOI: 10.1371/journal.pone.0024582. View